4//SEC Filing
Treace John T. 4
Accession 0000950170-25-032626
CIK 0001630627other
Filed
Mar 3, 7:00 PM ET
Accepted
Mar 4, 6:30 PM ET
Size
8.5 KB
Accession
0000950170-25-032626
Insider Transaction Report
Form 4
Treace John T.
DirectorChief Executive Officer10% Owner
Transactions
- Purchase
Common Stock
2025-03-04$8.73/sh+60,000$524,064→ 6,796,190 total
Holdings
- 1,605,000(indirect: By Spouse)
Common Stock
- 1,839,063(indirect: By Trust)
Common Stock
- 1,471,250(indirect: By Trust)
Common Stock
- 408,816(indirect: By Trust)
Common Stock
Footnotes (4)
- [F1]The price reported in Column 4 is a weighted average purchase price. These shares were bought in multiple transactions at prices ranging from $8.3150 to $8.9400 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares bought at each separate price within the range set forth in this footnote.
- [F2]Includes 437,536 restricted stock units
- [F3]The Reporting Person disclaims beneficial ownership of shares held by his wife directly or in trusts for which his wife serves as trustee or co-trustee.
- [F4]The Reporting Person disclaims beneficial ownership of shares held in trust for which he serves as trustee or co-trustee.
Documents
Issuer
TREACE MEDICAL CONCEPTS, INC.
CIK 0001630627
Entity typeother
Related Parties
1- filerCIK 0001856380
Filing Metadata
- Form type
- 4
- Filed
- Mar 3, 7:00 PM ET
- Accepted
- Mar 4, 6:30 PM ET
- Size
- 8.5 KB